Antimicrobial contact lenses and lens cases: A review

Eye and Contact Lens

Volumn 40, Issue 5, 2014, Pages 312-324

  Dutta, Debarun ^a,b   Willcox, Mark D P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BRIEN HOLDEN VISION INSTITUTE   (Australia)

Author keywords

Antimicrobial; Contact lens; Lens case.

Indexed keywords

ANTIINFECTIVE AGENT; BIOCIDE; POLYPEPTIDE ANTIBIOTIC AGENT; SELENIUM; SILVER NANOPARTICLE;

ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL CONTACT LEN; CONTACT LENS; PRIORITY JOURNAL; QUORUM SENSING; REVIEW;

EID: 84905302918     PISSN: 15422321     EISSN: 1542233X     Source Type: Journal    
DOI: 10.1097/ICL.0000000000000056     Document Type: Review

References (192)

1. Stapleton F, Dart JK, Minassian D. Risk factors with contact lens related suppurative keratitis. CLAO J 1993;19:204-210.
2. Stapleton F, Dart JK, Seal DV, et al. Epidemiology of Pseudomonas aeruginosa keratitis in contact lens wearers. Epidemiol Infect 1995;114: 395-402.
3. Stapleton F, Edwards K, Keay L, et al. Risk factors for moderate and severe microbial keratitis in daily wear contact lens users. Ophthalmology 2012;119:1516-1521.
4. Stapleton F, Keay L, Edwards K, et al. The epidemiology of microbial keratitis with silicone hydrogel contact lenses. Eye Contact Lens 2013;39: 79-85.
5. Stapleton F, Keay L, Edwards K, et al. The incidence of contact lensrelated microbial keratitis in Australia. Ophthalmology 2008;115:1655-1662.
6. Stapleton F, Keay L, Jalbert I, et al. The epidemiology of contact lens related infiltrates. Optom Vis Sci 2007;84:257-272.
7. Szczotka-Flynn L, Chalmers R. Incidence and epidemiologic associations of corneal infiltrates with silicone hydrogel contact lenses. Eye Contact Lens 2013;39:49-52.
8. Willcox MD, Holden BA. Contact lens related corneal infections. Biosci Rep 2001;21:445-461.
9. Szczotka-Flynn LB, Pearlman E, Ghannoum M. Microbial contamination of contact lenses, lens care solutions, and their accessories: A literature review. Eye Contact Lens 2010;36:116-129.
10. Wu P, Stapleton F, Willcox MD. The causes of and cures for contact lensinduced peripheral ulcer. Eye Contact Lens 2003;29:S63-S66.
11. Bourcier T, Thomas F, Borderie V, et al. Bacterial keratitis: Predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 2003;87:834-838.
12. Fong CF, Tseng CH, Hu FR, et al. Clinical characteristics of microbial keratitis in a university hospital in Taiwan. Am J Ophthalmol 2004;137: 329-336.
13. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology 2006;113:109-116.
14. Mela EK, Giannelou IP, Koliopoulos JX, et al. Ulcerative keratitis in contact lens wearers. Eye Contact Lens 2003;29:207-209.
15. Wong T, Ormonde S, Gamble G, et al. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 2003; 87:1103-1108.
16. Gebauer A, McGhee CN, Crawford GJ. Severe microbial keratitis in temperate and tropical Western Australia. Eye (Lond) 1996;10:575-580.
17. Rattanatam T, Heng WJ, Rapuano CJ, et al. Trends in contact lens-related corneal ulcers. Cornea 2001;20:290-294.
18. Lam DS, Houang E, Fan DS, et al. Incidence and risk factors for microbial keratitis in Hong Kong: Comparison with Europe and North America. Eye (Lond) 2002;16:608-618.
19. Poggio EC, Glynn RJ, Schein OD, et al. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med 1989;321:779-783.
20. Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contact- lensassociated microbial keratitis and its related morbidity. Lancet 1999;354: 181-185.
21. Seal DV, Kirkness CM, Bennett HG, et al. Population-based cohort study of microbial keratitis in Scotland: Incidence and features. Cont Lens Anterior Eye 1999;22:49-57.
22. Sankaridurg PR, Sharma S, Willcox MD, et al. Bacterial colonization of disposable soft contact lenses is greater during corneal infiltrative events than during asymptomatic extended lens wear. J Clin Microbiol 2000;38: 4420-4424.
23. Subbaraman L, Jones L. Measuring friction and lubricity of soft contact lenses: A review. Contact Lens Spectrum 2013;28(Special Edition):28-33.
24. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea 2008;27:22-27.
25. Schein OD, Ormerod LD, Barraquer E, et al. Microbiology of contact lensrelated keratitis. Cornea 1989;8:281-285.
26. Houang E, Lam D, Fan D, et al. Microbial keratitis in Hong Kong: Relationship to climate, environment and contact-lens disinfection. Trans R Soc Trop Med Hyg 2001;95:361-367.
27. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000;107:1497-1502.
28. Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea 2008;27:33-39.
29. Sankaridurg PR, Willcox MD, Sharma S, et al. Haemophilus influenzae adherent to contact lenses associated with production of acute ocular inflammation. J Clin Microbiol 1996;34:2426-2431.
30. Willcox MD, Sankaridurg PL, Zhu H, et al. Inflammation and Infection and the effects of the closed eye. In: Sweeney D, ed. Silicone Hydrogels: Contonuous-Wear Contact Lenses. Sydney, Australia, Butterworth-Heinemann, 2004, pp 90-125.
31. Sankaridurg PR, Sharma S, Willcox M, et al. Colonization of hydrogel lenses with Streptococcus pneumoniae: Risk of development of corneal infiltrates. Cornea 1999;18:289-295.
32. Willcox MD, Sweeney D, Sharma S, et al. Culture-negative peripheral ulcers are associated with bacterial-contamination of contact-lenses. Invest Ophthalmol Vis Sci 1995;36:S152.
33. Holden BA, Reddy MK, Sankaridurg PR, et al. Contact lens-induced peripheral ulcers with extended wear of disposable hydrogel lenses: Histopathologic observations on the nature and type of corneal infiltrate. Cornea 1999;18:538-543.
34. Jalbert I, Willcox MD, Sweeney DF. Isolation of Staphylococcus aureus from a contact lens at the time of a contact lens-induced peripheral ulcer: Case report. Cornea 2000;19:116-120.
35. Gorscak JJ, Ayres BD, Bhagat N, et al. An outbreak of Fusarium keratitis associated with contact lens use in the northeastern United States. Cornea 2007;26:1187-1194.
36. Yoder JS, Verani J, Heidman N, et al. Acanthamoeba keratitis: The persistence of cases following a multistate outbreak. Ophthalmic Epidemiol 2012;19:221-225.
37. Por YM, Mehta JS, Chua JL, et al. Acanthamoeba keratitis associated with contact lens wear in Singapore. Am J Ophthalmol 2009;148:7-12.e2.
38. Boost MV, Shi GS, Lai S, et al. Amoebicidal effects of contact lens disinfecting solutions. Optom Vis Sci 2012;89:44-51.
39. Hildebrandt C, Wagner D, Kohlmann T, et al. In-vitro analysis of the microbicidal activity of 6 contact lens care solutions. BMC Infect Dis 2012;12:241.
40. Haas W, Pillar CM, Torres M, et al. Monitoring antibiotic resistance in ocular microorganisms: Results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study. Am J Ophthalmol 2011;152:567-574.
41. Sharma S. Antibiotic resistance in ocular bacterial pathogens. Indian J Med Microbiol 2011;29:218-222.
42. Willcox MD. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom 2011;94:161-168.
43. Conibear TCR. A Study of Virulance Factors Associated With Pseudomonas aeruginosa Clinical Isolates [doctorial thesis]. Sydney, Australia: School of Optometry and Vision science, The University of New South Wales; 2006.
44. Tuft SJ, Matheson M. In vitro antibiotic resistance in bacterial keratitis in London. Br J Ophthalmol 2000;84:687-691.
45. Marangon FB, Miller D, Muallem MS, et al. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol 2004;137:453-458.
46. Zhu H, Conibear TC, Bandara R, et al. Type III secretion systemassociated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res 2006; 31:297-306.
47. Dart J. The inside story: Why contact lens cases become contaminated. Cont Lens Anterior Eye 1997;20:113-118.
48. Devonshire P, Munro FA, Abernethy C, et al. Microbial contamination of contact lens cases in the west of Scotland. Br J Ophthalmol 1993;77: 41-45.
49. Dantam J, Zhu H, Willcox M, et al. In vivo assessment of antimicrobial efficacy of silver-impregnated contact lens storage cases. Invest Ophthalmol Vis Sci 2012;53:1641-1648.
50. Wu YT, Zhu H, Harmis NY, et al. Profile and frequency of microbial contamination of contact lens cases. Optom Vis Sci 2010;87:E152-E158.
51. Willcox MD, Carnt N, Diec J, et al. Contact lens case contamination during daily wear of silicone hydrogels. Optom Vis Sci 2010;87:456-464.
52. McLaughlin-Borlace L, Stapleton F, Matheson M, et al. Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis. J Appl Microbiol 1998;84:827-838.
53. Keay L, Stapleton F, Schein O. Epidemiology of contact lens-related inflammation and microbial keratitis: A 20-year perspective. Eye Contact Lens 2007;33:346-353; discussion 362-363.
54. Dart JK, Radford CF, Minassian D, et al. Risk factors for microbial keratitis with contemporary contact lenses: A case-control study. Ophthalmology 2008;115:1647-1654.
55. Willcox MD, Hume EB, Vijay AK, et al. Ability of silver-impregnated contact lenses to control microbial growth colonisation. J Optom 2010;3: 143-148.
56. Nissen S, Furkert FH. Antimicrobial efficacy of a silver layer on hydrogel lenses [in German]. Ophthalmologe 2000;97:640-643.
57. Beattie TK, Tomlinson A, Seal DV, et al. Salicylate inhibition of acanthamoebal attachment to contact lenses. Optom Vis Sci 2011;88:1422-1432.
58. Arciola CR, Montanaro L, Caramazza R, et al. Inhibition of bacterial adherence to a high-water-content polymer by a water-soluble, nonsteroidal, anti-inflammatory drug. J Biomed Mater Res 1998;42:1-5.
59. Bandara BMK, Sankaridurg PR, Willcox MD. Non-steroidal anti inflammatory agents decrease bacterial colonisation of contact lenses and prevent adhesion to human corneal epithelial cells. Curr Eye Res 2004;29:245-251.
60. Tomlinson A, Simmons PA, Seal DV, et al. Salicylate inhibition of Acanthamoeba attachment to contact lenses: A model to reduce risk of infection. Ophthalmology 2000;107:112-117.
61. Dutta D, Cole N, Kumar N, et al. Broad spectrum antimicrobial activity of melimine covalently bound to contact lenses. Invest Ophthalmol Vis Sci 2013;54:175-182.
62. Cole N, Hume EB, Vijay AK, et al. In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU. Invest Ophthalmol Vis Sci 2010;51:390-395.
63. Willcox MD, Hume E, Aliwarga Y, et al. A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. J Appl Microbiol 2008;105:1817-1825.
64. Mathews SM, Spallholz JE, Grimson MJ, et al. Prevention of bacterial colonization of contact lenses with covalently attached selenium and effects on the rabbit cornea. Cornea 2006;25:806-814.
65. Zhu H, Kumar A, Ozkan J, et al. Fimbrolide-coated antimicrobial lenses: Their in vitro and in vivo effects. Optom Vis Sci 2008;85:292-300.
66. George M, Pierce G, Gabriel M, et al. Effects of quorum sensing molecules of Pseudomonas aeruginosa on organism growth, elastase B production, and primary adhesion to hydrogel contact lenses. Eye Contact Lens 2005; 31:54-61.
67. Selan L, Palma S, Scoarughi G, et al. Phosphorylcholine impairs susceptibility to biofilm formation of hydrogel contact lenses. Am J Ophthalmol 2009;147:134-139.
68. Harrison JJ, Ceri H, Stremick CA, et al. Biofilm susceptibility to metal toxicity. Environ Microbiol 2004;6:1220-1227.
69. Dallas P, Sharma VK, Zboril R. Silver polymeric nanocomposites as advanced antimicrobial agents: Classification, synthetic paths, applications, and perspectives. Adv Colloid Interf Sci 2011;166:119-135.
70. Abu-Youssef MAM, Soliman SM, Langer V, et al. Synthesis, crystal structure, quantum chemical calculations, DNA interactions, and antimicrobial activity of [Ag(2-amino-3-methylpyridine)(2)]NO3 and [Ag(pyridine- 2-carboxaldoxime)NO3]. Inorg Chem 2010;49:9788-9797.
71. Cavicchioli M, Massabni AC, Heinrich TA, et al. Pt(II) and Ag(I) complexes with acesulfame: Crystal structure and a study of their antitumoral, antimicrobial and antiviral activities. J Inorg Biochem 2010;104:533-540.
72. Dias HV, Batdorf KH, Fianchini M, et al. Antimicrobial properties of highly fluorinated silver(I) tris(pyrazolyl)borates. J Inorg Biochem 2006; 100:158-160.
73. Ramstedt M, Cheng N, Azzaroni O, et al. Synthesis and characterization of poly(3-sulfopropylmethacrylate) brushes for potential antibacterial applications. Langmuir 2007;23:3314-3321.
74. Sambhy V, MacBride MM, Peterson BR, et al. Silver bromide nanoparticle/polymer composites: Dual action tunable antimicrobial materials. J Am Chem Soc 2006;128:9798-9808.
75. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009;27:76-83.
76. Kasuga NC, Sugie A, Nomiya K. Syntheses, structures and antimicrobial activities of water-soluble silver(I)-oxygen bonding complexes with chiral and racemic camphanic acid (Hca) ligands. Dalton Trans 2004;3732-3740.
77. Shearer AE, Paik JS, Hoover DG, et al. Potential of an antibacterial ultraviolet-irradiated nylon film. Biotechnol Bioeng 2000;67:141-146.
78. Batarseh KI. Anomaly and correlation of killing in the therapeutic properties of silver (I) chelation with glutamic and tartaric acids. J Antimicrob Chemother 2004;54:546-548.
79. Klueh U, Wagner V, Kelly S, et al. Efficacy of silver-coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation. J Biomed Mater Res 2000;53:621-631.
80. Kumar R, Howdle S, Munstedt H. Polyamide/silver antimicrobials: Effect of filler types on the silver ion release. J Biomed Mater Res B Appl Biomater 2005;75:311-319.
81. Weisbarth RE, Gabriel MM, George M, et al. Creating antimicrobial surfaces and materials for contact lenses and lens cases. Eye Contact Lens 2007;33:426-429; discussion 434.
82. Lemire JA, Harrison JJ, Turner RJ. Antimicrobial activity of metals: Mechanisms, molecular targets and applications. Nat Rev Microbiol 2013;11: 371-384.
83. Dantam J, Zhu H, Stapleton F. Biocidal efficacy of silver-impregnated contact lens storage cases in vitro. Invest Ophthalmol Vis Sci 2011;52: 51-57.
84. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004;275:177-182.
85. Amro NA, Kotra LP, Wadu-Mesthrige K, et al. High-resolution atomic force microscopy studies of the Escherichia coli outer membrane: Structural basis for permeability. Langmuir 2000;16:2789-2796.
86. Amos CF, George MD. Clinical and laboratory testing of a silverimpregnated lens case. Cont Lens Anterior Eye 2006;29:247-255.
87. Sardi JC, Scorzoni L, Bernardi T, et al. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013;62:10-24.
88. Kim KJ, Sung WS, Suh BK, et al. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 2009;22:235-242.
89. Panacek A, Kolar M, Vecerova R, et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 2009;30:6333-6340.
90. Lo SF, Chang CJ, Hu WY, et al. The effectiveness of silver-releasing dressings in the management of non-healing chronic wounds: A metaanalysis. J Clin Nurs 2009;18:716-728.
91. Aziz Z, Abu SF, Chong NJ. A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns 2012;38:307-318.
92. Storm-Versloot MN, Vos CG, Ubbink DT, et al. Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010;3:CD006478.
93. Schumm K, Lam TB. Types of urethral catheters for management of shortterm voiding problems in hospitalised adults. Cochrane Database Syst Rev 2008;16:CD004013.
94. Liedberg H. Catheter induced urethral inflammatory reaction and urinary tract infection. An experimental and clinical study. Scand J Urol Nephrol Suppl 1989;124:1-43.
95. Saint S, Elmore JG, Sullivan SD, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: A meta-analysis. Am J Med 1998;105:236-241.
96. Drake PL, Hazelwood KJ. Exposure-related health effects of silver and silver compounds: A review. Ann Occup Hyg 2005;49:575-585.
97. Hau SC, Tuft SJ. Presumed corneal argyrosis from occlusive soft contact lenses: A case report. Cornea 2009;28:703-705.
98. Hong R, Kang TY, Michels CA, et al. Membrane lipid peroxidation in copper alloy-mediated contact killing of Escherichia coli. Appl Environ Microbiol 2012;78:1776-1784.
99. Espirito Santo C, Lam EW, Elowsky CG, et al. Bacterial killing by dry metallic copper surfaces. Appl Environ Microbiol 2011;77:794-802.
100. Harrison JJ, Turner RJ, Joo DA, et al. Copper and quaternary ammonium cations exert synergistic bactericidal and antibiofilm activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008;52:2870-2881.
101. Debbasch C, Brignole F, Pisella PJ, et al. Quaternary ammoniums and other preservatives contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001;42:642-652.
102. Fisher AA, Stillman MA. Allergic contact sensitivity to benzalkonium chloride. Cutaneous, ophthalmic, and general medical implications. Arch Dermatol 1972;106:169-171.
103. Brayner R, Dahoumane SA, Yepremian C, et al. ZnO nanoparticles: Synthesis, characterization, and ecotoxicological studies. Langmuir 2010;26: 6522-6528.
104. Barakat NA, Omran A, Aryal S, et al. Production of beads like hollow nickel oxide nanoparticles using colloidal-gel electrospinning methodology. J Mater Sci 2008;43:860-864.
105. Chang PR, Yu JG, Ma XF. Fabrication and characterization of Sb2O3/- carboxymethyl cellulose sodium and the properties of plasticized starch composite films. Macromolecular Mater Eng 2009;294:762-767.
106. Simon-Deckers A, Loo S, Mayne-Lhermite M, et al. Size-, compositionand shape-dependent toxicological impact of metal oxide nanoparticles and carbon nanotubes toward bacteria. Environ Sci Technol 2009;43: 8423-8429.
107. Kumar A, Pandey AK, Singh SS, et al. Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells. Chemosphere 2011;83:1124-1132.
108. Hajipour MJ, Fromm KM, Ashkarran AA, et al. Antibacterial properties of nanoparticles. Trends Biotechnol 2012;30:499-511.
109. Keskin S, Kizilel S. Biomedical applications of metal organic frameworks. Ind Eng Chem Res 2011;50:1799-1812.
110. Bondarenko O, Juganson K, Ivask A, et al. Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: A critical review. Arch Toxicol 2013;87:1181-1200.
111. Muller E, Al-Attar J, Wolff AG, et al. Mechanism of salicylate-mediated inhibition of biofilm in Staphylococcus epidermidis. J Infect Dis 1998;177: 501-503.
112. Hussain M, Wilcox MH, White PJ. The slime of coagulase-negative staphylococci: Biochemistry and relation to adherence. FEMS Microbiol Rev 1993;10:191-207.
113. Muller E, Takeda S, Shiro H, et al. Occurrence of capsular polysaccharide adhesin among clinical isolates of coagulase-negative staphylococci. J Infect Dis 1993;168:1211-1218.
114. Farber BF, Hsieh HC, Donnenfeld ED, et al. A novel antibiofilm technology for contact lens solutions. Ophthalmology 1995;102:831-836.
115. Simmons PA, Tomlinson A, Seal DV. The role of Pseudomonas aeruginosa biofilm in the attachment of Acanthamoeba to four types of hydrogel contact lens materials. Optom Vis Sci 1998;75:860-866.
116. Beattie TK, Tomlinson A, McFadyen AK, et al. Enhanced attachment of Acanthamoeba to extended-wear silicone hydrogel contact lenses: A new risk factor for infection? Ophthalmology 2003;110:765-771.
117. Beattie TK, Tomlinson A, McFadyen AK. Attachment of Acanthamoeba to first- and second-generation silicone hydrogel contact lenses. Ophthalmology 2006;113:117-125.
118. Venter JC. Immobilized and insolubilized drugs, hormones, and neurotransmitters: Properties, mechanisms of action and applications. Pharmacol Rev 1982;34:153-187.
119. Fraunfelder FW. Corneal toxicity from topical ocular and systemic medications. Cornea 2006;25:1133-1138.
120. Ganz T. The role of antimicrobial peptides in innate immunity. Integr Comp Biol 2003;43:300-304.
121. Kolar SS, McDermott AM. Role of host-defence peptides in eye diseases. Cell Mol Life Sci 2011;68:2201-2213.
122. McDermott AM. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res 2009;41:60-75.
123. McDermott AM. Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf 2004;2:229-247.
124. Hancock RE, Lehrer R. Cationic peptides: A new source of antibiotics. Trends Biotechnol 1998;16:82-88.
125. Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 2011;29: 464-472.
126. Yount NY, Bayer AS, Xiong YQ, et al. Advances in antimicrobial peptide immunobiology. Biopolymers 2006;84:435-458.
127. Wang G, Li X, Wang Z. APD2: The updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 2009;37: D933-D937.
128. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-395.
129. Scott MG, Hancock RE. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 2000;20:407-431.
130. Hoffmann JA, Kafatos FC, Janeway CA, et al. Phylogenetic perspectives in innate immunity. Science 1999;284:1313-1318.
131. Hancock RE. Cationic peptides: Effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 2001;1:156-164.
132. Hamamoto K, Kida Y, Zhang Y, et al. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol Immunol 2002;46:741-749.
133. Murakami T, Niwa M, Tokunaga F, et al. Direct virus inactivation of tachyplesin I and its isopeptides from horseshoe crab hemocytes. Chemotherapy 1991;37:327-334.
134. Masuda M, Nakashima H, Ueda T, et al. A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II). Biochem Biophys Res Commun 1992;189:845-850.
135. Costa F, Carvalho IF, Montelaro RC, et al. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomater 2011;7:1431-1440.
136. Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006;24:1551-1557.
137. Rasul R, Cole N, Balasubramanian D, et al. Interaction of the antimicrobial peptide melimine with bacterial membranes. Int J Antimicrob Agents 2010; 35:566-572.
138. Turner J, Cho Y, Dinh NN, et al. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 1998;42:2206-2214.
139. Schroder JM. Epithelial peptide antibiotics. Biochem Pharmacol 1999;57: 121-134.
140. Ganz T, Lehrer RI. Defensins. Pharmacol Ther 1995;66:191-205.
141. Dutta D, Willcox MD. Antimicrobial activity of melimine or cathelicidin bound to contact lenses. Invest Ophthalmol Vis Sci 2013;54: E-Abstract 507.
142. Rasul R. Novel Antimicrobial Biomaterials [doctorial thesis]. Sydney, Australia: School of Optometry and Vision Science, The University of New South Wales; 2010.
143. Andersson DI, Hughes D. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev 2011;35:901-911.
144. Li Y, Santos CM, Kumar A, et al. "Click" immobilization on alkylated silicon substrates: Model for the study of surface bound antimicrobial peptides. Chemistry 2011;17:2656-2665.
145. McDermott A, Santos CM, Kolar SS, et al. Antimicrobial activity of a cathelicidin derivative covalently attached to fluorous surfaces. Invest Ophthalmol Vis Sci 2010;51: E-Abstract 3433.
146. Kolar SS, Kumar A, Cai C, et al. Antimicrobial activity of a cathelicidin derivative conjugated to polymerized-liposomes. Invest Ophthalmol Vis Sci 2010;51: E-Abstract 431.
147. Gabriel M, Nazmi K, Veerman EC, et al. Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug Chem 2006;17:548-550.
148. Huang LC, Jean D, Proske RJ, et al. Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res 2007;32:595-609.
149. Huang LC, Petkova TD, Reins RY, et al. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci 2006; 47:2369-2380.
150. Huang LC, Redfern RL, Narayanan S, et al. In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid. Antimicrob Agents Chemother 2007;51:3853-3860.
151. Yeung AT, Gellatly SL, Hancock RE. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 2011; 68:2161-2176.
152. Carnt NA, Willcox MD, Hau S, et al. Immune defense single nucleotide polymorphisms and recruitment strategies associated with contact lens keratitis. Ophthalmology 2012;119:1997-2002.
153. Aspedon A, Groisman EA. The antibacterial action of protamine: Evidence for disruption of cytoplasmic membrane energization in Salmonella typhimurium. Microbiology 1996;142:3389-3397.
154. Johansen C, Gill T, Gram L. Antibacterial effect of protamine assayed by impedimetry. J Appl Bacteriol 1995;78:297-303.
155. Aliwarga Y, Hume EB, Lan J, et al. Antimicrobial peptides: A potential role in ocular therapy. Clin Experiment Ophthalmol 2001;29:157-160.
156. Chen R, Cole N, Willcox MD, et al. Synthesis, characterization and in vitro activity of a surface-attached antimicrobial cationic peptide. Biofouling 2009;25:517-524.
157. Willcox MD, Hume EB, Aliwarga Y, et al. A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. J Appl Microbiol 2008;105:1817-1825.
158. Dutta D, Cole N,Willcox MD. Antimicrobial efficacy of melimine covalently bound to contact lenses. Invest Ophthalmol Vis Sci 2012;53: E-Abstract 6085.
159. Dutta D, Willcox MD. Biocompatibility and antimicrobial activity of melimine-coated contact lenses in a rabbit and human clinical trial. Optom Vis Sci 2014;91:570-581.
160. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev 2006;19:491-511.
161. Feigl F, West PW. Test for selenium based on a catalytic effect. Anal Chem 1947;19:351-353.
162. Spallholz JE, Shriver BJ, Reid TW. Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: Implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine. Nutr Cancer 2001; 40:34-41.
163. Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med 1994;17:45-64.
164. Rayman MP. Selenium in cancer prevention: A review of the evidence and mechanism of action. Proc Nutr Soc 2005;64:527-542.
165. Palace VP, Spallholz JE, Holm J, et al. Metabolism of selenomethionine by rainbow trout (Oncorhynchus mykiss) embryos can generate oxidative stress. Ecotoxicol Environ Saf 2004;58:17-21.
166. Tran PL, Hammond AA, Mosley T, et al. Organoselenium coating on cellulose inhibits the formation of biofilms by Pseudomonas aeruginosa and Staphylococcus aureus. Appl Environ Microbiol 2009;75:3586-3592.
167. Tran P, Hamood A, Jarvis C, et al. Organo-selenium coated contact lenses: Effect upon bacterial biofilm attachment. Invest Ophthalmol Vis Sci 2012; 53: E-Abstract 6086.
168. Reid T, Tran P, Jarvis C, et al. Antimicrobial properties of selenium covalently incorporated into the polymer of contact lens case material. Invest Ophthalmol Vis Sci 2012;53: E-Abstract 6081.
169. Selenium Ltd. Selenium Ltds breakthrough technology used in new FDAapproved orthodontic product line from class one orthodontics. 2009. Available at: http://www.selenbio.com/pdfs/20090211-SeLECT-DeFENSELaunce. pdf. Accessed December 13, 2013.
170. Mohammadi Z, Palazzi F, Giardino L, et al. Microbial biofilms in endodontic infections: An update review. Biomed J 2013;36:59-70.
171. Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998;280:295-298.
172. Baveja JK, Willcox MD, Hume EB, et al. Furanones as potential antibacterial coatings on biomaterials. Biomaterials 2004;25:5003-5012.
173. Levy LM, Cabrera GM, Wright JE, et al. 5H-furan-2-ones from fungal cultures of Aporpium caryae. Phytochemistry 2003;62:239-243.
174. Wu H, Song Z, Hentzer M, et al. Synthetic furanones inhibit quorumsensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J Antimicrob Chemother 2004;53:1054-1061.
175. Dutta D, Cole N, Willcox M. Factors influencing bacterial adhesion to contact lenses. Mol Vis 2012;18:14-21.
176. Reichelt JL, Borowitzka MA. Antimicrobial activity from marine-algae-Results of a large-scale screening-program. Hydrobiologia 1984;116:158-168.
177. Ho KK, Cole N, Chen R, et al. Characterisation and in vitro activities of surface attached dihydropyrrol-2-ones against gram-negative and grampositive bacteria. Biofouling 2010;26:913-921.
178. Holden BA, La Hood D, Grant T, et al. Gram-negative bacteria can induce contact lens related acute red eye (CLARE) responses. CLAO J 1996;22: 47-52.
179. Kingshott P, Wei J, Bagge-Ravn D, et al. Covalent attachment of poly (ethylene glycol) to surfaces, critical for reducing bacterial adhesion. Langmuir 2003;19:6912-6921.
180. Kingshott P, Thissen H, Griesser HJ. Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins. Biomaterials 2002;23:2043-2056.
181. Willcox MD, Harmis N, Williams T, et al. Bacterial interactions with contact lenses; effects of lens material, lens wear and microbial physiology. Biomaterials 2001;22:3235-3247.
182. Salwiczek M, Qu Y, Gardiner J, et al. Emerging rules for effective antimicrobial coatings. Trends Biotechnol 2014;32:82-90.
183. Tiffany J. Biochemistry of Eye. London, Chapman & Hall, 1997.
184. Lakkis C, Anastasopoulos F, Slater J, et al. The effect of silver-infused silicone hydrogel contact lenses on the ocular biota during daily wear. Cont Lens Anterior Eye 2011;34: E-Abstract.
185. Lacazette E, Gachon AM, Pitiot G. A novel human odorant-binding protein gene family resulting from genomic duplicons at 9q34: Differential expression in the oral and genital spheres. Hum Mol Genet 2000;9:289-301.
186. Willcox MD. Management and treatment of contact lens-related Pseudomonas keratitis. Clin Ophthalmol 2012;6:919-924.
187. Vijay AK, Sankaridurg PL, Zhu H, et al. Guinea pig models of acute keratitis responses. Cornea 2009;28:1153-1159.
188. Wu PZ, Zhu H, Stapleton F, et al. Effects of alpha-toxin-deficient Staphylococcus aureus on the production of peripheral corneal ulceration in an animal model. Curr Eye Res 2005;30:63-70.
189. Szczotka-Flynn L, Lass JH, Sethi A, et al. Risk factors for corneal infiltrative events during continuous wear of silicone hydrogel contact lenses. Invest Ophthalmol Vis Sci 2010;51:5421-5430.
190. ISO 9394. Ophthalmic optics-Contact lenses and contact lens care products-Determination of biocompatibility by ocular study using rabbit eyes. Int Organ Standardization 2012.
191. Wei XE, Markoulli M, Millar TJ, et al. Divalent cations in tears, and their influence on tear film stability in humans and rabbits. Invest Ophthalmol Vis Sci 2012;53:3280-3285.
192. Gans J, Wolinsky M, Dunbar J. Computational improvements reveal great bacterial diversity and high metal toxicity in soil. Science 2005;309: 1387-1390.